<<

. 54
( 61 .)



>>

cines for Peace Programme, Stockholm International Peace Research Insti-
tute (1994).
Genomics and the Global Health Divide, World Health Organization, available at
http://who.int/genomics/healthdivide/en/print.html.
Ghanaian Chronicle, The Day of Scientific Renaissance of Africa, Africa News ( June
30, 2005).
Glenn, Jerome C., & Theodore Gordon, Update on the State of the Future: Environ-
mental Sustainability, Global Partnerships Against Terror, Technology, and Drug
Availability Figure in Humanity™s Future, Futurist (January 1, 2006).
Goldman, Michael A., Promises and Perils of Technology™s Future; Living with the
Genie Essays on Technology and the Quest for Human Mastery, Science (January
30, 2004).
Gomez-Pompa, Arturo, The Role of Biodiversity Scientists in a Troubled World; Ple-
nary, BioScience (March 1, 2004).
Gonzalez, Andres Guandamuz, Open Science: Open Source Licenses in Scientific
Research, 7 N. C. J. L. & Tech. 321 (Spring 2006).
Gorman, Brian J., Balancing National Security and Open Science: A Proposal for Due
Process Vetting, 7 Yale Journal of Law & Technology 59 (2004“2005).
Gorman, Brian J., Biosecurity and Secrecy Policy: Problems, Theory, and a Call for
Executive Action, I/S: A Journal of Law and Policy, Vol. 2.1 (2006).
Gould, Ronald M., & Simon Stern, Catastrophic Threats and the Fourth Amendment,
77 S. Cal. L. Rev. 777 (May 2004).
318 BIBLIOGRAPHY

Greenberger, Michael, Choking BioShield: The Department of Homeland Secu-
rity™s Stranglehold on Biodefense Vaccine Development, Microbe Magazine
( June 2006).
Grobowski, Henry, Encouraging the Development of New Vaccines, 24 Health
Affairs 697 (2005).
Guidelines to Prevent Malevolent Use of Biomedical Research, American Medical
Association ( June 2004).
Hanney, Stephen R., et al., The Utilisation of Health Research in Policy-Making:
Concepts, Examples, and Methods Assessment, Health Research Policy and Sys-
tems, Vol. 1, No. 2 (January 13, 2003).
Hawkins, Andrew J., National Biosecurity Advisory Board Members Stress Balance,
International Implications, Research Policy Alert ( July 1, 2005).
Healthy People 2010, Immunizations and Infectious Disease, U.S. Depart-
ment of Health and Human Services, available at http://www.healthypeople
.gov/Document/HTML/Volume1/14Immunization.htm.
Hearing before the Bioterrorism and Public Health Preparedness Subcommittee,
Committee on Health, Education, Labor, and Pensions, United States Senate, on
Biodefense: Building a Medical Countermeasure Capability (February 8, 2005),
Testimony of Gerald L. Epstein.
Hearing before the House Armed Services Committee, Military Procurement and
Military Research and Development Subcommittees (October 20, 1999), Testi-
mony of Hans Mark.
Hearing before the House Armed Services Committee, Terrorism, Unconventional
Threats and Capabilities Subcommittee, on Counterterrorism Technology Shar-
ing (July 21, 2005), Testimony of Tony Tether.
Hearing before the House Government Reform Committee, on Bioshield Oversight
(July 14, 2005), Testimonies of John Vitko Jr. and Stewart Simonson.
Hearing before the House Homeland Security Committee, Emergency Prepared-
ness, Science, and Technology Subcommittee, on Linking Bioterrorism Threats
and Countermeasure Procurement (July 12, 2005), Testimony of Dr. John
Vitko.
Hearing before the House Homeland Security Committee, Prevention of Nuclear
and Biological Attack Subcommittee, on Engineering Biological Weapons (July
13, 2005), Testimonies of Dr. Kenneth Alibek and Michael V. Callahan.
Hearing before the House Science Committee, Research Subcommittee, on Plant
Biotechnology Research in Africa (June 12, 2003), Testimony of Dr. Rita Colwell.
Hearing before the House Select Homeland Security Committee, on National Biode-
fense Strategy (June 3, 2004), Testimonies of Anna Johnson-Winegar, Anthony S.
Fauci, and Shelley Hearne.
Hearing before the Senate Armed Services Committee, Emerging Threats and Capa-
bilities Subcommittee, on Biological Terrorism: Department of Defense Research
and Development (April 10, 2002), Testimony of Dr. Dale Klein.
Hearing before the Senate Commerce, Science and Transportation Committee,
Science, Technology and Space Subcommittee, on Fighting Terrorism: Using
319
BIBLIOGRAPHY

America™s Scientists and Entrepreneurs to Find Solutions (February 5, 2002), Tes-
timony of Dr. Anna Johnson-Winegar.
Hearing before the Senate Commerce, Science and Transportation Committee,
Disaster Prevention and Prediction Subcommittee, on Research and Development
to Protect America™s Communities from Disaster (June 8, 2005), Testimony of Dr.
Hratch G. Semerjian.
Hearing before the Senate Committee on Health, Education, Labor, and Pensions,
on The National Immunization Program: Is It Prepared for the Public Health
Challenges of the 21st Century?, 107th Congress, 1st Session (November 27,
2001), Statement of Dr. John E. Calfee.
Hearing before the Senate Health, Education, Labor, and Pensions Committee, on
Biodefense: Next Steps (February 8, 2005), Testimony of Dr. George Painter.
Hearing before the Senate Health, Labor, Education, Labor, and Pensions Com-
mittee, on Liability Protection for Makers of Bioshield Drugs (October 6, 2004),
Testimonies of Jeff Kushan, John G. Bartlett, and Joseph Lieberman.
Hearing before the Senate Judiciary Committee, on Bioterrorism Detection and
Response (May 11, 2004), Testimony of Dr. Harvey Meislin.
Hearing of the House Armed Services Committee, on Terrorism, Unconventional
Threats and Capabilities Subcommittee, on Fiscal Year 2004 Science and Technol-
ogy Programs (March 27, 2003).
Hearing of the House Government Reform Committee, on Project Bioshield Evalu-
ation (July 14, 2005).
Hearing of the National Security, Veterans Affairs and International Relations Sub-
committee of the House Government Reform Committee, on Biological Weapons
Convention (September 13, 2000).
Hearing of the Senate Appropriations Committee, Homeland Security Subcommit-
tee, on Bioterrorism and Bioshield (April 28, 2005).
Heller, Nathan J., Scientists Balance Research with Security Demands, Harvard
Crimson (May 9, 2003).
Henderson, Diedtra, New Rules Dictate Lab Safety Fort Collins Research Facility
Among Those Handling Infectious Agents, Denver Post (November 27, 2003).
Hernandez, Nelson, Ebola™s Dogged Enemies; Team of Fort Detrick Scientists Labored
for Years to Develop Vaccine, Washington Post (October 2, 2005).
Ho, Cynthia M., Inoculation Inventions: The Interplay of Infringement and Immu-
nity in the Development of Biodefense Vaccines, 8 J. Health Care L. & Pol™y 111
(2005).
Hoen, Ellen F. M., The Responsibility of Research Universities to Promote Access to
Essential Medicines, 3 Yale J. Health Pol™y L. & Ethics 293(Summer 2003).
Homeland Security Act of 2002, Public Law 107“296, Title VIII, Subtitle G, §§ 862“865,
116 Stat. 2238“2241 (November 25, 2002).
Human Development Report 2001: Making New Technologies Work for Human
Development, United Nations Development Programme (2001).
IAP Statement on Biosecurity, The Interacademy Panel on International Issues,
(November 7, 2005).
320 BIBLIOGRAPHY

Inspection of the FBI™s Security Risk Assessment Program for Individuals Requesting
Access to Biological Agents and Toxins, U.S. Department of Justice (March 2005).
Integrity and Misconduct in Research, Report of the Commission on Research
Integrity, U.S. Department of Health and Human Services, USGPO 19960746“
425 (1995).
Integrity in Scientific Research: Creating an Environment that Promotes Responsible
Conduct, Institute of Medicine (2002).
Intentional Biology and Open-Source Biology, The Molecular Sciences Institute
(December 10, 2000).
Is Bioshield Doing the Job? 24 Biotechnology L. Rep. 56 (February 2005).
IUMS Code of Ethics Against Misuse of Scientific Knowledge, Research,
and Resources, International Union of Microbial Societies (April 28,
2006).
Jack, Andrew, Cut-price HIV Drugs Drive May Spur Patents Clash, Financial Times
(London) (August 11, 2006).
Jackson, Ronald J., et al., Expression of Mouse Interleukin-4 by a Recombinant
Ectromelia Virus Suppresses Cytolytic Lymphocyte Responses and Overcomes
Genetic Resistance to Mousepox, Journal of Virology (February 2001).
Jacobi, Paula, Pharmaceutical Tort Liability: A Justifiable Nemesis to Drug Innova-
tion and Access?, 38 J. Marshall L. Rev. 987 (Spring 2005).
Javitt, Gail H., Drugs and Vaccines for the Common Defense: Refining FDA Regula-
tion to Promote the Availability of Products to Counter Biological Attacks, 19 J.
Contemp. Health L. & Pol™y 37 (Winter 2002).
Jenkins, Michael; Scherr, Sara J.; & Inbar, Mira, Markets for Biodiversity Services:
Potential Roles and Challenges, Environment ( July 1, 2004).
Ji-Wei, Guo, & Xue-Sen Yang, Ultramicro, Nonlethal, and Reversible: Looking
Ahead to Military Biotechnology; Transformation, Military Review, Vol. 85, No. 4
( July 1, 2005).
Johnson, Steve, U.S. Dumps VaxGen: Brisbane Company Had Won $877.5 Mil-
lion Contract to Develop Anthrax Vaccine, Mercury News (December 19,
2006).
Juma, Calestous, Biotechnology in a Globalizing World: The Co-Evolution of Tech-
nology and Social Institutions, BioScience (March 1, 2005).
Kahn, Laura H., Biodefense Research: Can Secrecy and Safety Coexist?, Biosecurity
and Bioterrorism: Biodefense Strategy, Practice, and Science,Vol. 2, No. 2
(2004).
Kaiser, Jocelyn et al., Bioterrorism: Bioshield is Slow to Build U.S. Defenses Against
Bioweapons, Science, Vol. 313, No. 28 (2006).
Kellman, Barry, Chemical Weapons Convention Inspections of Private Facilities:
Application of United States Environmental and Safety Laws (DNA-TR-93“70)
(1993).
Kellman, Barry, Legal Implications Special Access Visits under START: Revoking
Consent; Visits on Foreign Soil; Gaining Access to Department of Defense Con-
tractor Facilities (September 1, 1993).
321
BIBLIOGRAPHY

Khan, Michael J., & Daya B. Reddy, Science and Technology in South Africa: Regional
Innovation Hub or Passive Consumer?, Daedalus (January 1, 2001).
Knox, John H., A New Approach to Compliance with International Environmental
Law: The Submissions Procedure of the NAFTA Environmental Commission, 28
Ecology Law Quarterly 1 (2001).
Koblenz, Gregory, Countering Dual-use Facilities: Lessons from Iraq and Sudan,
Jane™s Intelligence Review (March 1999).
Kurzweil, Ray, An Exponentially Expanding Future from Exponentially Shrink-
ing Technology, Council on Foreign Relations (December 2, 2005).
Kurzweil, Ray, The Singularity Is Near, Penguin Books (2005).
Kwik, Jeanna, Preventing the Misuse of Biotechnology, Panel discussion of the
Carnegie International Non-Proliferation Conference (November 15, 2002).
Lacayo, Arnoldo, Seeking a Balance: International Pharmaceutical Patent Protec-
tion, Public Health Crises, and the Emerging Threat of BioTerrorism, 33 U. Miami
Inter-Am. L. Rev. 295 (Summer/Fall 2002).
Lam, Clarence, Crystal Franco, & Ari Schuler, Billions for Biodefense: Federal Agency
Biodefense Funding, FY2006-FY2007, 4 Biosecurity & Bioterrorism 113 (2006).
Lavery, James V., Commentary: Putting International Research Ethics Guidelines to
Work for the Benefit of Developing Countries, 4 Yale J. Health Pol™y L. & Ethics
319 (Summer 2004).
Lawler, Andrew, The Unthinkable Becomes Real for a Horrified World; Research and
Development to Combat Terrorism; Statistical Data Included, Science (September
21, 2001).
Lederberg, Joshua, The Freedoms and the Control of Science: Notes from the Ivory
Tower, 45 S. Cal. L. Rev. 596 (1972).
LeRoy, Michael H., Pox Americana? Vaccinating More Emergency Doctors for
Smallpox: A Law and Economics Approach to Work Conditions, 54 Emory Law
Journal (Winter 2005).
Liability Protections for Adult Vaccines, Reports of Board of Trustees, Report 10,
American Medical Association, Resolution 710-I04 (June 2005).
Lipman, Zada, Gene Technology Regulation and the Precautionary Principle: How
Australia Measures Up, 8 J. Int™l Wildlife Law & Pol™y 1 (January 1, 2005).
Lipton, Eric, Bid to Stockpile Bioterror Drugs Stymied by Setbacks, New York Times
(September 18, 2006).
Lohan, Dagmar, Assessing the Mechanisms for the Input of Scientific Information
into the UNFCCC, 17 Colo. J. Int™l Envtl. L. & Pol™y 249 (Spring 2006).
Mair, J. S., & M. Mair, Vaccine Liability in the Era of Bioterrorism, Biosecurity and
Bioterrorism: Biodefense Strategy, Practice, and Science, Vol. 1 (2003).
Making the Nation Safer: The Role of Science and Technology in Countering
Terrorism, The National Academies Press (2002).
Marshall, Patricia, & Barbara Koenig, Accounting for Culture in Globalized Bioethics,
32 J.L. Med. & Ethics 252 (Summer 2004).
Maskus, Keith E., Using the International Trading System to Foster Technology
Transfer for Economic Development, Mich. St. L. Rev. 219 (Spring 2005).
322 BIBLIOGRAPHY

Maurer, Stephen M., Keith V. Lucas, & Starr Terrell, From Understanding to Action:
Community-Based Options for Improving Safety and Security in Synthetic Biology,
University of California at Berkeley (April 15, 2006).
McDonald, Barry P., Government Regulation or other “Abridgements” of Scientific
Research: The Proper Scope of Judicial Review Under the First Amendment, 54
Emory L.J. 979 (Spring 2005).
McMichael, Anthony J., et al., Globalization and the Sustainability of Human
Health: An Ecological Perspective, BioScience (March 1, 1999).
Mello, Michelle M., & Troyen A. Brennan, Legal Concerns and the Influenza Vaccine
Shortage, Journal of the American Medical Association, Vol. 294, No. 14 (2005).
Melson, Ashley R., Bioterrorism, Biodefense, and Biotechnology in the Military: A
Comparative Analysis of Legal and Ethical Issues in the Research, Development,
and Use of Biotechnological Products on American and British Soldiers, 14 Alb.
L.J. Sci. & Tech. 497 (2004).
Merle, Renae, Bioterror Antidote: Unfulfilled Prescription, Washington Post (Jan-
uary 16, 2007).
Milstien, Julie B., Regulation of Vaccines: Strengthening the Science Base, Journal
of Public Health Policy, Vol. 25, No. 2 (2004).
Mitchell, Ronald B., Sources of Transparency: Information Systems in International
Regimes, International Studies Quarterly, Vol. 42, No. 1 (March 1998).
Mock, William B. T., An Interdisciplinary Introduction to Legal Transparency: A Tool
for Rational Development, 18 Dick. J. Int™l L. 293 (Winter 2000).
Monge-Najera, Julian, & Vanessa Nielsen, The Countries and Languages that Domi-
nate Biological Research at the Beginning of the 21st Century, Revista de Biolog´a
±
Tropical, Vol. 53, No. 1“2 (March 1, 2005).
Monshipouri, Mahmood, Promoting Universal Human Rights: Dilemmas of Inte-
grating Developing Countries, 4 Yale H.R. & Dev. L.J. 25 (2001).
Mordini, Emilio, Conclusions of the International Conference on Ethical Implica-
tions of Research into the Prevention of Bioterrorism, Bioethical Implications of
Globalization Processes, Policy Paper 1(April 2004).
Moynihan, Mark F., The Scientific Community and Intelligence Collection, Physics
Today, Vol. 53, No. 12 (December 2000).
Mullin, Thomas F., Aids, Anthrax, and Compulsory Licensing: Has the United States
Learned Anything? A Comment on Recent Decisions on the International Intellec-
tual Property Rights of Pharmaceutical Patents, 9 ILSA J. Int™l & Comp. L. 185 (Fall
2002).
Munro, Neil, Securing Science, National Journal (September 6, 2003).
Nanda, Ved P Sustainable Development, International Trade and the Doha Agenda
.,
for Development, 8 Chap. L. Rev. 53 (Spring 2005).
Nanosignificance, Statesman (India) (April 3, 2006).
National Childhood Vaccine Injury Act of 1986, 42 USC §30aa.
National Science Advisory Board for Biosecurity Charter, Department of Health
and Human Services (March 4, 2004).
323
BIBLIOGRAPHY

Natsios, Andrew S., The Nine Principles of Reconstruction and Development, Param-
eters, Vol. 35, No. 3 (September 22, 2005).
Neuman, Victor A., & John P. Martin, Biosafety Level 4 Labs: Up Close and Personal:
More High-containment Biosafety Level 4 Labs are Being Built Today to Address
the Twin Threats of Terrorism and Infectious Diseases, Heating/Piping/Air Con-
ditioning Engineering, No. 3, Vol. 77 (March 1, 2005).
Nonpharmaceutical Interventions for Pandemic Influenza, National and Commu-
nity Measures, World Health Organization Writing Group, Policy Review, Emerg-
ing Infectious Diseases, Vol. 12, No. 1 (January 2006).
Notes on the Scope of Diseases to be Covered in the Paragraph Six ˜Solution™ (Decem-
ber 20, 2002).
Null, Gary, (Ph.D.), Germs, Biological Warfare, Vaccinations, Seven Stories Press

<<

. 54
( 61 .)



>>